Two Series A rounds for cultivated meat startups in one week: Future Meat Technologies raises $14 million

October 15, 2019
Emerging Ecosystems in Agrifood and Health More...
by Thomas Hayes
Average importance

This comes within days of a $12.5 million Series A round for Wild Type. Future Meat Technologies and Wild Type now join the ranks of Mosa Meat, Aleph Farms, and Memphis Meats in reaching Series A stage in the cultivated meat space, with Memphis Meats rumored to be closing a $250 million Series B round soon. Future Meat now plans to expand its R&D efforts and build a pilot production facility by the end of 2020. It aims to introduce hybrid products combining both plant-based and cell-based meats in 2021, followed by 100% cell-based meats in 2022. This is in line with Lux's commercialization roadmap for the broader cellular agriculture space and underscores that plant-based and cell-based meats are not mutually exclusive development areas.

For the original news article, click here .

Further Reading

InnovoPro's $15 million Series B indicates growing momentum for second-generation proteins

News Commentary | April 27, 2020

This Series B round was led by Jerusalem Venture Partners, with participation from several other strategic investors, bringing InnovoPro's total funding to $20.8 million. The company plans to use this fund to expand the production capacity of its chickpea protein concentrate as well as to focus on ... Not part of subscription

Shiok Meats raises $12.6 million Series A for cell-based crustacean meat

News Commentary | September 30, 2020

Aqua‑Spark led the round, which comes shortly after Shiok raised a $3 million bridge round in June 2020. This latest raise brings the company's total funding to $20.4 million. The funding will go toward construction of a commercial pilot facility, with Shiok eyeing 2022 for the release of cell‑based... Not part of subscription

Qualitas Health raises $10 million to expand to the alternative protein market

News Commentary | January 13, 2021

The round was led by PeakBridge VC and joined by Minrav, Arancia, and other investors. Qualitas Health grows algae in open raceway ponds to produce omega‑3 supplements (under the iwi brand). The company will use the funding to further its sales, research, and clinical testing efforts and accelerate ... Not part of subscription